Financial Ratios

MERCURY LABORATORIES LTD.

NSE : NABSE : 538964ISIN CODE : INE947G01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE846.00-44.1 (-4.95 %)
PREV CLOSE ( ) 890.10
OPEN PRICE ( ) 924.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 506
TODAY'S LOW / HIGH ( )846.00 930.00
52 WK LOW / HIGH ( ) 535.11303
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)46.4929.6844.4826.9023.63
   CEPS(Rs)67.1850.1260.4842.4837.20
   DPS(Rs)3.503.503.502.001.50
   Book NAV/Share(Rs)380.24335.89307.46266.48241.38
   Tax Rate(%)25.5529.2532.5125.4329.98
Margin Ratios
   Core EBITDA Margin(%)11.3812.0713.9810.7710.31
   EBIT Margin(%)10.439.4612.468.999.26
   Pre Tax Margin(%)9.958.6911.537.567.30
   PAT Margin (%)7.416.157.785.645.11
   Cash Profit Margin (%)10.7010.3810.588.908.04
Performance Ratios
   ROA(%)8.585.578.775.685.20
   ROE(%)12.989.2315.5010.5910.26
   ROCE(%)16.2912.2620.5613.2513.77
   Asset Turnover(x)1.160.911.131.011.02
   Sales/Fixed Asset(x)1.731.381.771.591.69
   Working Capital/Sales(x)2.982.973.623.483.71
Efficiency Ratios
   Fixed Capital/Sales(x)0.580.730.570.630.59
   Receivable days92.32123.77108.21119.27111.78
   Inventory Days33.1437.6128.3839.1747.57
   Payable days128.23225.52178.16210.82199.88
Valuation Parameters
   PER(x)12.5916.3414.4510.4514.34
   PCE(x)8.719.6810.626.629.11
   Price/Book(x)1.541.442.091.051.40
   Yield(%)0.600.720.540.710.44
   EV/Net Sales(x)0.910.971.160.670.88
   EV/Core EBITDA(x)6.647.237.585.477.21
   EV/EBIT(x)8.6910.299.287.469.49
   EV/CE(x)1.010.901.210.680.85
   M Cap / Sales0.931.001.120.590.73
Growth Ratio
   Net Sales Growth(%)30.06-15.5619.793.157.04
   Core EBITDA Growth(%)31.82-25.4549.263.6839.88
   EBIT Growth(%)43.31-35.9066.140.1552.81
   PAT Growth(%)56.62-33.2765.3413.8240.87
   EPS Growth(%)56.62-33.2765.3413.8240.87
Financial Stability Ratios
   Total Debt/Equity(x)0.120.130.190.220.33
   Current Ratio(x)2.542.242.012.091.89
   Quick Ratio(x)2.121.811.731.731.48
   Interest Cover(x)21.7012.2813.336.304.72
   Total Debt/Mcap(x)0.080.090.090.210.23

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.